September 4, 2019
Mayo experts provide insights into how genes affect medication response
By Advancing the Science contributor
By Sharon Rosen Pharmacogenomics – how a person’s genes affect medication response – is touching virtually every area of medical care. Findings from the Mayo Clinic RIGHT study (Right Drug, Right Dose, Right Time–Using Genomic Data to Individualize Treatment) showed that 99% of participants had at least one genetic variant that may affect their response […]
Tags: breast cancer, cancer, cancer genomics, Center for Individualized Medicine, Eric Matey, Lauren Cornell, mental health, Michael Shuh, neurology, opioids, pharmacogenomics, pharmacy
August 6, 2019
Researching stem cell therapy for hemorrhagic stroke
By Jen Schutz
Stroke is the leading cause of permanent disability in the U.S., striking nearly 800,000 people each year, according to the Centers for Disease Control and Prevention. In the last decade, there has been preclinical research that led to a small number of early phase clinical trials using mesenchymal stem cells (MSCs) as a possible treatment to reverse […]
Tags: Center for Regenerative Medicine, regenerative medicine, research, stem cells, stroke, Toni Turnbull, William Freeman
September 4, 2018
Research News Roundup-August 2018
The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. Mayo Clinic researchers identify a potential new approach to treat HER2 positive breast cancer Researchers at Mayo Clinic have identified an important […]
Tags: breast cancer, deep space medicine, Fergus Couch, Mayo Clinic Proceedings, Michelle Freeman, Molly Jeffery, opioids, Purna Kashyap, Research News Roundup, Taro Hitosugi, weight loss, William Freeman